Eczema is a common long‐term condition, but inadequate support and information can lead
to poor adherence and treatment failure. We have reviewed the international literature of …

Atopic dermatitis (AD) is a multisystem inflammatory disorder that exists within the spectrum
of diseases of atopy, that is AD, food and environmental allergies, and asthma, all of which …

Objective To assess the Uniformed Services Constipation Action Plan (USCAP) as an
evidence-based, personalized, clinical action tool with pictograms to aid clinicians and …

Background: Treatment of atopic dermatitis and psoriasis in children is difficult due to lack of
standardized treatment guidelines and few FDA-approved treatment options. Treatments …

Background Atopic dermatitis (AD) is a chronic, inflammatory skin disease that affects as
many as 12.5% of children aged 0-17 years and 3% of the adult population. In the United …

To optimally tailor atopic dermatitis (AD) care to patients' needs, especially considering the
many emerging therapeutic options, insight into patients' needs and preferences regarding …

Background Alpine climate treatment has historically been used in Europe to treat atopic
dermatitis (AD), but no randomized trials have been conducted to provide evidence for its …

The multitude of treatment options for atopic dermatitis (AD) makes management frustrating
for providers and patients. Eczema action plans (EAPs) have been proposed to improve …

Objective To develop and assess an evidence-based, individualized Cyclic Vomiting
Syndrome Action Plan (CVSAP) to optimize both preventative and acute care. Study design …

Background Management and treatment of atopic dermatitis (AD) are complex and therefore
bear the risk of therapeutic failure. Individualised patient action plans for patients and for …